Pharmaxis CF Drug Gets Mixed Review

Published January 30, 2013

Pharmaxis CF Drug Gets Mixed Review

Filed under: drug addiction treatment statistics

The second trial showed the drug increased FEV1 by 54 mL, but that result didn't achieve statistical significance (P=0.059). However, as the FDA noted, that analysis doesn't account for the "frequent and treatment-related early discontinuations in the …
Read more on MedPage Today

Follow the Money to These 2 Areas of Unmet Medical Needs

Filed under: drug addiction treatment statistics

One of the few FDA-approved drugs, Amyvid by Eli Lilly (NYSE: LLY ) , isn't even a treatment at all. It's merely a process-of-elimination test that determines … Other high-profile treatment attempts failed to reach the mark in recent months …
Read more on Motley Fool

Public debate of sexual abuse is long overdue

Filed under: drug addiction treatment statistics

She had been sexually exploited by a street gang who got her hooked on cocaine from the age of 13, and made her exchange sex for drugs; she had also been sexually abused by a relative at the age of eight – in neither case had she seen justice. However …
Read more on The Guardian (blog)